Dengue Vaccines Market, By End User (Hospitals, Government Institutes, NGOs), By Geography ( North America, Latin America, Middle East, Africa and Asia Pacific)

Description

Dengue Vaccines Market is estimated to be valued at USD 434.8 Mn in 2026 and is expected to reach USD 1,689.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 434.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	14.30%	2033 Value Projection:	USD 1,689.7 Mn

Dengue fever is a mosquito-borne viral infection causing a severe flu-like illness. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Dengue is most likely to affect individual's tropical and subtropical countries. Increasing prevalence of dengue is expected to propel growth of the global dengue vaccine market over the forecast period.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Dengue Vaccine based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Dengue Vaccine report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

By End User
- Hospitals
- Government Institutes
- NGOs
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline
- Merck & Co

Product Code: CMI23

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Product Approval
Regulatory Scenario

4. Global Dengue Vaccine Market, By End User 2026- 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Government Institutes
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
NGOs
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Dengue Vaccine Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
North America
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Asia Pacific
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa
  - Rest of World
- Market Size and Forecast, By End User, 2026-2033, (USD Mn)
- Market Size and Forecast, By Country, 2026-2033, (USD Mn)

6. Competitive Landscape

Company Profiles
- Sanofi
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

7. Section

References
Research Methodology
About us and Sales Contact